Compare Batavia Prosperindo Internasional Tbk (BPII) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Batavia Prosperindo Internasional Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Batavia Prosperindo Internasional Tbk trades at Rp436 (market cap 4.37T, 4.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.18M 24h volume). The key difference: Batavia Prosperindo Internasional Tbk is far larger — about 7.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.18M versus 4.1K). Which is the better fit depends on your goals.
| BPII | LABS | |
|---|---|---|
Market Cap | 4.37T | 576.7B |
Volume | 4.1K | 3.18M |
Lot | 41 | 31.77K |
Turnover | 1.8M | 477.74M |
Average Price | 440.05 | 150.39 |
Value | 1.8M | 477.74M |
Indicative Equilibrium Price | — | 147 |
Indicative Equilibrium Volume | — | 311 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Batavia Prosperindo Internasional Tbk
PT Batavia Prosperindo Internasional Tbk (the Company) was established based on Notarial Deed No. 78 dated November 12, 1998 of Irawan Soerodjo, S.H., notary in Jakarta.
Read more on BPII →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
